1. Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?. (1st November 2017) Authors: Cardones, A.R.; Hall, R.P. Journal: British journal of dermatology Issue: Volume 177:Number 5(2017) Page Start: 1145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?. (30th November 2017) Authors: Cardones, A.R.; Hall, R.P. Journal: British journal of dermatology Issue: Volume 177:Number 5(2017) Page Start: 1145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease. (18th August 2019) Authors: Blanchard, S.K.; Sullivan, K.M.; Hooten, J.N.; Holcomb, Z. E.; Rowe Nichols, K.; Selim, M.A.; Rao, C.L.; Hall, R.P.; Chao, N.J.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease. (1st October 2019) Authors: Blanchard, S.K.; Sullivan, K.M.; Hooten, J.N.; Holcomb, Z. E.; Rowe Nichols, K.; Selim, M.A.; Rao, C.L.; Hall, R.P.; Chao, N.J.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SCLE and dermatomyositis in anti‐PD‐1 therapy. (1st September 2019) Authors: Marano, A.L.; Clarke, J.M.; Morse, M.A.; Shah, A.; Barrow, W.; Selim, M.A.; Hall, R.P.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SCLE 和皮肌炎与抗 PD‐1 治疗. (1st September 2019) Authors: Marano, A.L.; Clarke, J.M.; Morse, M.A.; Shah, A.; Barrow, W.; Selim, M.A.; Hall, R.P.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: e85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti‐programmed cell death 1 therapy. (10th December 2018) Authors: Marano, A.L.; Clarke, J.M.; Morse, M.A.; Shah, A.; Barrow, W.; Selim, M.A.; Hall, R.P.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti‐programmed cell death 1 therapy. (1st September 2019) Authors: Marano, A.L.; Clarke, J.M.; Morse, M.A.; Shah, A.; Barrow, W.; Selim, M.A.; Hall, R.P.; Cardones, A.R. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗